ID
36916
Description
Study ID: 101468/201 Clinical Study ID: 101468/201 Study Title: A Single Blind, Parallel Group, Up-titration, Phase 1 Study in Healthy Volunteers to Determine a Starting Dose and Select an Up-titration Regimen for a new Formulation of Ropinirole Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Restless Legs Syndrome The Study consists of 21 Visits(Days): Screening (at least 21 days before dosing) Week 1: including Day 1-7 Week 2: including Day 8-14 Week 3: including Day 15-19 Follow-up Visit (7-14 days after last dose) This document contains the Baseline Signs And Symptoms for Screening form.
Keywords
Versions (1)
- 6/21/19 6/21/19 -
Copyright Holder
GlaxoSmithKline
Uploaded on
June 21, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Determination of starting dose and up-titration regimen for a new formulation of Ropinirole in healthy adults, 101468/201
Baseline Signs And Symptoms for Screening
- StudyEvent: ODM
Description
Non-serious Adverse Event
Alias
- UMLS CUI-1
- C1518404 (Non-serious Adverse Event)
Description
Non-serious Adverse Event
Data type
boolean
Alias
- UMLS CUI [1]
- C1518404 (Non-serious Adverse Event)
Description
Record any baseline events (using standard medical terminology) observed or elicited by the following direct question to the subject: “How do you feel?“ Provide the diagnosis, NOT symptoms where possible. (One baseline event per column)
Data type
text
Alias
- UMLS CUI [1]
- C0037088 (Signs and Symptoms)
- SNOMED
- 404684003
- LOINC
- LP185402-7
Description
day month year
Data type
date
Alias
- UMLS CUI [1]
- C2985916 (Adverse Event Onset Date)
Description
00:00-23:59
Data type
time
Alias
- UMLS CUI [1,1]
- C0449244 (Time of onset)
- SNOMED
- 263501003
- UMLS CUI [1,2]
- C1518404 (Non-serious Adverse Event)
Description
day month year
Data type
date
Alias
- UMLS CUI [1]
- C2697886 (Adverse Event End Date)
Description
00:00-23:59
Data type
time
Alias
- UMLS CUI [1,1]
- C1518404 (Non-serious Adverse Event)
- UMLS CUI [1,2]
- C1522314 (End Time)
- SNOMED
- 397898000
Description
Outcome
Data type
integer
Alias
- UMLS CUI [1]
- C1705586 (Adverse Event Outcome)
Description
Experience Course
Data type
integer
Alias
- UMLS CUI [1,1]
- C0877248 (Adverse event)
- LOINC
- MTHU014542
- UMLS CUI [1,2]
- C0750729 (Course)
- SNOMED
- 288524001
Description
Number of episodes
Data type
integer
Alias
- UMLS CUI [1,1]
- C0877248 (Adverse event)
- LOINC
- MTHU014542
- UMLS CUI [1,2]
- C4086638 (Number of Episodes)
Description
MILD: An event which is easily tolerated MODERATE: An event which is sufficiently discomforting to interfere with daily activity SEVERE: An event which prevents normal everyday activities
Data type
integer
Alias
- UMLS CUI [1]
- C1710066 (Severity of Adverse Event)
Description
NOT RELATED: The event is definitely not related to the study procedures UNLIKELY: There are other more likely causes and the study procedures are not suspected as a cause SUSPECTED (REASONABLE POSSIBILITY): A direct cause and effect relationship between the study procedures and the event has not been demonstrated but there is a reasonable possibility that the study procedures were involved PROBABLE: There probably is a direct cause and effect relationship between the event and the study procedures
Data type
integer
Alias
- UMLS CUI [1,1]
- C0008976 (Clinical Trials)
- SNOMED
- 110465008
- LOINC
- LP231796-6
- UMLS CUI [1,2]
- C2700391 (Procedure (set of actions))
Description
If ‘Yes’, record details in the Concomitant Medication section and/or Healthcare Resource Utilisation form if appropriate
Data type
text
Alias
- UMLS CUI [1,1]
- C0877248 (Adverse event)
- LOINC
- MTHU014542
- UMLS CUI [1,2]
- C0087111 (Therapeutic procedure)
- SNOMED
- 277132007
- LOINC
- LP21090-3
Description
patient withdrawn due to this specific AE
Data type
text
Alias
- UMLS CUI [1,1]
- C0422727 (Patient withdrawn from trial)
- SNOMED
- 185924006
- UMLS CUI [1,2]
- C1518404 (Non-serious Adverse Event)
Description
Investigator signature
Data type
text
Alias
- UMLS CUI [1]
- C2346576 (Investigator Signature)
Description
day month year
Data type
date
Alias
- UMLS CUI [1]
- C0011008 (Date in time)
- SNOMED
- 410671006
Similar models
Baseline Signs And Symptoms for Screening
- StudyEvent: ODM
C1518404 (UMLS CUI [1,2])
C1522314 (UMLS CUI [1,2])
C4086638 (UMLS CUI [1,2])
C2700391 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,2])
No comments